And what SeekPeptides members should know before starting or adjusting a retatrutide protocol
Although this initial case only involves the drug manufacturers as defendants, it is anticipated that more claims and lawsuits targeting not only Ozempic, but also other GLP-1 drugs, will emerge
The 2023 Phase 2 trial reported up to 24.2% mean loss at 48 weeks [2]
Lemme claims its GLP-1 Daily helps control appetite and fat by supporting your bodys own GLP-1 production, the same hormone mimicked by medications like Ozempic and Wegovy
The injectable form allows for once-weekly dosing and typically delivers more consistent blood levels than oral formulations, making it a preferred choice for patients who can tolerate needle injections
But the gap between those results, the side effect profiles, the costs, and the long-term sustainability of each approach has grown so wide that choosing the wrong one for your situation could mean years of frustration